Post Date: June 18, 2021

"Linda Matthews Continues to Blaze Trails and Transform BioCare, Inc."

Bitbean “CEOs Speak”

Post Date: May 10, 2021

We Spoke to Linda Matthews of BioCare

Authority Magazine

Post Date: May 3, 2021

"Women of the C-Suite: Linda Matthews of BioCare on the Five Things You Need to Succeed As A Senior Executive"

Managed Healthcare Executive: Tuning into the C-Suite

Post Date: May 3, 2021

"The Evolution of Delivering Therapy in Healthcare and How to Expand Your Healthcare Business Today"

ADMA Biologics Announces BioCareSD Selected as Primary Authorized Distributor of ASCENIV™ and First Commercial Sales

Post Date: October 21, 2019

BioCareSD has been selected by ADMA Biologics, Inc. as the primary authorized national distributor for ASCENIV. ASCENIV is a plasma-derived, polyclonal human immune globulin product.  ASCENIV is indicated for the treatment of Primary Humoral Immunodeficiency or Primary...

BioCareSD Selected Primary Authorized Distributor for BIVIGAM®

Post Date: September 16, 2019

BioCareSD has been selected by ADMA Biologics, Inc. as the primary authorized national distributor for BIVIGAM®. BIVIGAM®[Immune Globulin Intravenous (Human), 10% Liquid] is indicated for the treatment of primary humoral immunodeficiency (PI). Linda Matthews, president of BioCareSD, said,...

Linda Matthews Named One Of The 2018 PM360 ELITE 100

Post Date: May 24, 2017

PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, and medical device sectors, has named Linda Matthews, President, BioCareSD, Inc., as one of the 2018 PM360 ELITE 100 in the Transformational Leader...

BioCare to Become Separate Company January 1, 2017

Post Date: January 1, 2017

Blood Systems, Incorporated has announced that the operations of BioCare, its plasma and biological therapeutics sales division, will be transferred to BioCare, Inc., a separate, for-profit subsidiary of Blood Systems, effective January 1, 2017. Blood Systems...

BioCare Selected as Exclusive Distributor for Ceprotin

Post Date: October 27, 2016

Manufacturer Shire has named BioCare as the exclusive, national authorized distributor for CEPROTIN, a Protein C concentrate replacement therapy. It is indicated for the prevention and treatment of venous thrombosis and purpura fulminans for pediatric and adult...

Octapharma’s NUWIQ Available at BioCare

Post Date: January 15, 2016

BioCare is excited to announce that Octapharma’s NUWIQ is now available. Nuwiq is the first and only recombinant FVIII produced in human cells without chemical modification. It is indicated in children and adults with Hemophilia A for on-demand treatment &...